Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response

Journal of Clinical Endocrinology &amp Metabolism (Impact Factor: 6.31). 03/2009; 94(2):703. DOI: 10.1210/me.2008-0361
Source: PubMed

ABSTRACT Somatostatin (SRIF) binds G protein-coupled SRIF receptor subtypes (SST1, -2, -3, -4, and -5) to regulate cell secretion and proliferation. Hypothalamic SRIF inhibits pituitary growth hormone, thyroid stimulating hormone, and ACTH secretion. We tested SRIF-independent constitutive SST activity in AtT20 mouse pituitary corticotroph cells in which ACTH secretion is highly sensitive to SRIF action. Stable transfectants expressing SST2 or SST5 were sensitized to selective agonist action, and constitutive SST receptor activity was demonstrated by forskolin and pertussis toxin cAMP cell responses. Persistent constitutive SST activity decreased cell ACTH responses to CRH through decreased expression of CRH receptor subtype 1. Decreased dopamine receptor type 1 expression was associated with attenuated dopamine agonist action, whereas responses to isoproterenol were enhanced through increased beta 2-adrenoreceptor expression. Thus, integrated pituitary cell ACTH regulation is determined both by phasic SRIF action, as well as by tonic constitutive SST activity, independently of SRIF. (Molecular Endocrinology 23: 337-348, 2009)

  • [Show abstract] [Hide abstract]
    ABSTRACT: cAMP signalling plays a key role in the normal physiology of the pituitary gland, regulating cellular growth and proliferation, hormone production and release. Deregulation of the cAMP signalling pathway has been reported to be a common occurrence in pituitary tumorigenesis. Several mechanisms have been implicated including somatic mutations, gene-gene interactions and gene – environmental interactions. Somatic mutations in G-proteins and protein kinases directly alter cAMP signalling, while malfunctioning of other signalling pathways such as the Raf/MAPK/ERK, PI3K/Akt/mTOR and Wnt pathways which normally interact with the cAMP pathway may mediate indirect effects on cAMP and varying downstream effectors. The aryl hydrocarbon receptor signalling pathway has been implicated in pituitary tumorigenesis and we review its role in general and specifically in relation to cAMP de-regulation.
    Molecular and Cellular Endocrinology 07/2014; 392(1-2). DOI:10.1016/j.mce.2014.05.004 · 4.24 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Contemporary (event to decadal-scale) morphological changes in two large braided rivers in Canterbury, New Zealand, are described, along with laboratory studies that support the field observations. In the process, some new developments in field and laboratory methods for investigating morphological change in braided rivers are presented, and Paola's (2001) hypothesis that braiding tendency should be influenced by a river's ability to turn over its bed within the characteristic time for riparian vegetation to establish and grow to a mature, scour-resistant state is examined. The lower Waitaki River has been regulated for hydropower since 1935, and since then vegetation has encroached over the riverbed and braiding intensity for a given discharge has reduced. Measurements of vegetation removal by floods indicate that floods are not able to turn over the bed fast enough to contain vegetation encroachment, and the present braiding state is held by virtue of a regular spraying programme. In contrast, on the unregulated and sparsely vegetated Waimakariri River, remotely sensed high-resolution topographic surveys using LiDAR and digital photogrammetry have shown that even sub-annual floods turn over large proportions of the braidplain. The laboratory studies show that a braided river will evolve into a single-thread channel when its bed is invaded by vegetation and floods are too infrequent to contain the vegetation growth. Collectively, the field and laboratory evidence confirms that Paola's (2001) dimensionless time-scale parameter is a reasonable first-order predictor of whether floods or vegetation will achieve ascendancy, driving a river towards either braided or single-thread end-points, respectively.
    Developments in Earth Surface Processes 11:557-584. DOI:10.1016/S0928-2025(07)11143-3
  • [Show abstract] [Hide abstract]
    ABSTRACT: Somatostatin signals predominantly through somatostatin receptor (SSTR) subtype 2 to attenuate GH release. However, the independent role of the receptor in regulating GH synthesis is unclear. Because we had previously demonstrated constitutive SSTR2 activity in mouse corticotrophs, we now analyzed GH regulation in rat pituitary somatotroph (GC) tumor cells, which express SSTR2 exclusively and are devoid of endogenous somatostatin ligand. We demonstrate that moderately stable SSTR2 overexpression (GpSSTR2WT cells) was associated with decreased GH promoter activity, GH mRNA, and hormone levels compared with those of control transfectants (GpCon cells). In contrast, levels of GH mRNA and peptide and GH promoter activity were unchanged in GpSSTR2DRY stable transfectants moderately expressing DRY motif mutated SSTR2 (R140A). GpSSTR2DRY did not exhibit an enhanced octreotide response as did GpSSTR2WT cells; however, both SSTR2WT-enhanced yellow fluorescent protein (eYFP) and SSTR2DRY-eYFP internalized on octreotide treatment. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, increased GH synthesis in wild-type GC cells and primary pituitary cultures. GpSSTR2WT cells induced GH synthesis more strongly on SAHA treatment, evident by both higher GH peptide and mRNA levels compared with the moderate but similar GH increase observed in GpCon and GpSSTR2DRY cells. In vivo SAHA also increased GH release from GpSSTR2WT but not from control xenografts. Endogenous rat GH promoter chromatin immunoprecipitation showed decreased baseline acetylation of the GH promoter with exacerbated acetylation after SAHA treatment in GpSSTR2WT compared with that of either GpSSTR2DRY or control cells, the latter 2 transfectants exhibiting similar GH promoter acetylation levels. In conclusion, modestly increased SSTR2 expression constitutively decreases GH synthesis, an effect partially mediated by GH promoter histone deacetylation.
    Endocrinology 05/2013; 154(7). DOI:10.1210/en.2013-1132 · 4.64 Impact Factor